COVID-19 Records

Gates Package — page 1372

of 1375 pages

← p.1371 p.1373 → · this page in the original PDF · package

COARPA) Technical Approach- University of California Davis (UCD) Developing animal species-specific cytomegalovirus (CMV)-based transmissible vaccines for Lassa virus (LASV) and Ebola virus (EBOV) Three Interwoven Strands Virus Ecology Modelling Vaccine Development + What animal species serve as * When and where is the highest * Can the vaccine vector be isolated the major reservoir host? risk for spillover? from reservoir animals? + What CMY and pathogen virus + When is it optimal to introduce + Can the vaccine have a limiting halflineages are co-circulating in transmissible vaccine, and at what life "i.e, off-switch" to control these reservoir hosts? dose? environmental dissemination? + What is the incidence and + When are animals most + Doss the vaccine prevent infection prevalence of pathogen in these susceptible to vaccine and shedding virus? animals? intervention?

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/gates/1372

Records on this page

RecordDateTypePages
gates:exh:00644 attachment 1372